Prevail Innovative Wealth Advisors’s Colgate-Palmolive CL Stock Holding History

Prevail Innovative Wealth Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Buy	+2,873	New	+$251K	0.04%	171

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Prevail Innovative Wealth Advisors's CL Position: Q2 2026 in Review

Prevail Innovative Wealth Advisors opened a new position in Colgate-Palmolive (CL) in Q2 2026: 2,873 shares worth $263K. The stake represents 0.04% of the portfolio and ranks #171 among its holdings.

2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Prevail Innovative Wealth Advisors held 2,873 shares of Colgate-Palmolive worth $263K as of Q2 2026.
Colgate-Palmolive was a new Prevail Innovative Wealth Advisors position in Q2 2026.
Colgate-Palmolive made up 0.04% of Prevail Innovative Wealth Advisors's portfolio in Q2 2026, its #171 holding.
2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Prevail Innovative Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.